Evidence map›Paper›PMID 24404179›Full record

ArticlePloS one2014

ADAM10 negatively regulates neuronal differentiation during spinal cord development.

Xin Yan, Juntang Lin, Venkata Ajay Narendra Talabattula, Carolin Mußmann, Fan Yang, Andreas Wree, Arndt Rolfs, Jiankai Luo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Xin YanAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
Juntang LinKey Laboratory for Medical Tissue Regeneration of Henan Province, Xinxiang Medical University, Xinxiang, P.R. China ; Institute of Anatomy I, School of Medicine University of Jena, Jena, Germany.
Venkata Ajay Narendra TalabattulaAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
Carolin MußmannAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
Fan YangAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
Andreas WreeInstitute of Anatomy, School of Medicine University of Rostock, Rostock, Germany.
Arndt RolfsAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
Jiankai LuoAlbrecht-Kossel-Institute for Neuroregeneration, School of Medicine University of Rostock, Rostock, Germany.
University of Rostock · DEFriedrich Schiller University Jena · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the ADAM (a disintegrin and metalloprotease) family are involved in embryogenesis and tissue formation via their proteolytic function, cell-cell and cell-matrix interactions. ADAM10 is expressed temporally and spatially in the developing chicken spinal cord, but its function remains elusive. In the present study, we address this question by electroporating ADAM10 specific morpholino antisense oligonucleotides (ADAM10-mo) or dominant-negative ADAM10 (dn-ADAM10) plasmid into the developing chicken spinal cord as well as by in vitro cell culture investigation. Our results show that downregulation of ADAM10 drives precocious differentiation of neural progenitor cells and radial glial cells, resulting in an increase of neurons in the developing spinal cord, even in the prospective ventricular zone. Remarkably, overexpression of the dn-ADAM10 plasmid mutated in the metalloprotease domain (dn-ADAM10-me) mimics the phenotype as found by the ADAM10-mo transfection. Furthermore, in vitro experiments on cultured cells demonstrate that downregulation of ADAM10 decreases the amount of the cleaved intracellular part of Notch1 receptor and its target, and increases the number of βIII-tubulin-positive cells during neural progenitor cell differentiation. Taken together, our data suggest that ADAM10 negatively regulates neuronal differentiation, possibly via its proteolytic effect on the Notch signaling during development of the spinal cord.

Indexed as

Cell DifferentiationADAM10 ProteinADAM ProteinsAmyloid Precursor Protein SecretasesAnimalsCell ProliferationChick EmbryoGene Expression RegulationHumansMembrane ProteinsNeurogliaNeuronsProtein Interaction Domains and MotifsReceptors, NotchSignal TransductionSpinal CordADAM10 ProteinADAM10 protein, humanADAM ProteinsAmyloid Precursor Protein SecretasesMembrane ProteinsReceptors, Notch

Identifiers

PMID24404179
PMCPMC3880303
OpenAlexW2018765983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.